Vafseo
Total Payments
$1.4M
Transactions
2,438
Doctors
1,581
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.4M | 2,438 | 1,581 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.2M | 1 | 83.0% |
| Consulting Fee | $163,029 | 45 | 11.5% |
| Education | $30,976 | 1,306 | 2.2% |
| Food and Beverage | $30,762 | 1,030 | 2.2% |
| Travel and Lodging | $17,243 | 56 | 1.2% |
Payments by Type
Research
$1.2M
1 transactions
General
$242,010
2,437 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Safety of Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Hemodialysis Subjects: Vafseo Outcomes In-Center Experience | AKEBIA THERAPEUTICS INC | $1.2M | 0 |
Top Doctors Receiving Payments for Vafseo
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Plano, TX | $1.2M | 1 |
| Osama El Shamy | Internal Medicine | Franklin, TN | $11,182 | 12 |
| , MD | Internal Medicine | Surprise, AZ | $9,647 | 11 |
| , MD | Nephrology | Orlando, FL | $9,472 | 9 |
| , MD | Nephrology | Los Angeles, CA | $9,302 | 9 |
| , MD | Nephrology | Indianapolis, IN | $8,646 | 9 |
| , MD | Nephrology | St. Louis, MO | $8,630 | 9 |
| John Middleton | Nephrology | Durham, NC | $7,286 | 6 |
| , M.D | Emergency Medicine | Norfolk, MA | $7,159 | 9 |
| , MD | Nephrology | Odessa, TX | $6,835 | 8 |
| , M.D | Nephrology | Orangeburg, SC | $6,832 | 8 |
| , M.D | Nephrology | Woodbridge, VA | $6,784 | 12 |
| , M.D | Internal Medicine | Webster, TX | $6,715 | 8 |
| , M.D | Nephrology | Victoria, TX | $6,573 | 7 |
| , M.D | Nephrology | Wexford, PA | $6,101 | 17 |
| , MD | Nephrology | Bay City, MI | $5,970 | 9 |
| , MD | Internal Medicine | Palo Alto, CA | $5,960 | 1 |
| , M.D | Internal Medicine | Winston Salem, NC | $5,727 | 7 |
| , DO | Nephrology | Salina, KS | $5,618 | 10 |
| , M.D., SC.D | Internal Medicine | Houston, TX | $4,720 | 1 |
| , M.D | Internal Medicine | El Paso, TX | $2,950 | 1 |
| , M.D | Nephrology | Needham, MA | $2,700 | 4 |
| , D.O | Internal Medicine | Los Angeles, CA | $2,680 | 2 |
| , MD | Internal Medicine | Carmel, IN | $2,673 | 3 |
| , M.D | Nephrology | Beaufort, SC | $2,665 | 2 |
Ad
Manufacturing Companies
- AKEBIA THERAPEUTICS INC $1.4M
Product Information
- Type Drug
- Total Payments $1.4M
- Total Doctors 1,581
- Transactions 2,438
About Vafseo
Vafseo is a drug associated with $1.4M in payments to 1,581 healthcare providers, recorded across 2,438 transactions in the CMS Open Payments database. The primary manufacturer is AKEBIA THERAPEUTICS INC.
Payment data is available from 2024 to 2024. In 2024, $1.4M was paid across 2,438 transactions to 1,581 doctors.
The most common payment nature for Vafseo is "Unspecified" ($1.2M, 83.0% of total).
Vafseo is associated with 1 research study, including "Safety of Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Hemodialysis Subjects: Vafseo Outcomes In-Center Experience" ($1.2M).